NEWS

Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock

BOCA RATON, Fla., Sept. 12, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ :SRTS ), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that it commenced a public offering of its common stock, par value $0.01 per share. Sensus intends to use the net proceeds from the offering primarily […]

Read More

Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting

BOCA RATON, Fla., Sept. 7, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ : SRTS ), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, participated at the National Cancer Care Alliance (NCCA) Leadership Board and Practice Quarterly Meeting, which took place Thursday, […]

Read More

ASDS Annual Meeting

Join Sensus Healthcare at the ASDS Annual Meeting in Phoenix, AZ October 11th – 14th. For tickets and more information click here.

Read More

Sensus Healthcare to Participate in Two Upcoming Investor Conferences

BOCA RATON, Fla., Aug. 27, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (Nasdaq :SRTS ), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will participate at two investor conferences in September 2018. Read the full press release here.

Read More

2018 ASTRO Annual Meeting

Come see Sensus Healthcare at booth #1017 at the 2018 ASTRO Annual Meeting in San Antonio, Texas October 21st – 24th. For tickets and more information click here.

Read More

Inc: 19 Ideas on How to Push Yourself to the Next Level

Inc. recently sat down with 19 successful founders and executives to discuss how they push themselves to the next level. When asked about his support system, CEO of Sensus Healthcare, Joe Sardano, said, “One maxim our team hangs onto is, ‘Who packs your parachute?’ This saying comes from an old story originated by a U.S. Navy […]

Read More

OWM Industry Spotlight: Joe Sardano

CEO, Chairman and Co-Founder of Sensus Healthcare, Joe Sardano, was recently interviewed for a feature in AAWC‘s research journal, Ostomy Wound Management (OWM). Read the full interview here.

Read More

Fall Clinical Dermatology Conference

Join Sensus Healthcare at the Fall Clinical Dermatology Conference in Las Vegas, NV October 18th – 21st, 2018. For tickets and more information click here.

Read More

5CC in Barcelona

Join Sensus Healthcare at the 5-Continent-Congress (5CC) in Barcelona, Spain August 30th – September 2nd, 2018. For tickets and more information click here.

Read More

Sensus Healthcare CEO Receives “Innovator of the Year” Award at The Aesthetic Show 2018

BOCA RATON, Fla., July 31, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), today announced that the Company’s CEO, Joe Sardano, has been named non-physician, nonsurgical “Innovator of the Year” at the 2018 Aesthetic Awards, hosted by The Aesthetic […]

Read More

2018 AAMP Annual Meeting

Join Sensus Healthcare at the 2018 AAMP Annual Meeting in Nashville, TN July 29th – August 2nd, 2018. For tickets and more information click here.

Read More

Dr. Kevin Schewe on Colorado’s Best – Non-Surgical Technology for Skin Cancer – Alliance Cancer Care at Red Rocks

Dr. Kevin Schewe the Radiation Oncologist and Medical Director at Alliance Cancer Care at Red Rocks discusses the dangers of UV rays, the different types of skin cancer and SRT with Colorado’s Best on FOX network Channel 2 and Channel 31 in Denver. Watch the video here.

Read More

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

BOCA RATON, Fla., July 12, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), today announced a strategic agreement focused on marketing the SRT-100 Vision™ with SkinCure Oncology, a leading turnkey provider of IGSRT solutions in the dermatology industry. […]

Read More

People Magazine – 42-Year-Old Woman Has Survived 86 Skin Cancer Surgeries

Lisa Pace has had 86 skin cancer surgeries and she’s only 42 years old. She was in her 20s when she discovered she had skin cancer after years of using tanning beds. In her interview with People Magazine, she discusses the importance of sun-protection and the dangers of tanning beds. She adds: “I want people to realize that it can […]

Read More

Sensus Healthcare to Join Russell Microcap® Index

BOCA RATON, Fla., June 25, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that it is set to join the Russell Microcap® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective before the U.S. market […]

Read More

WFN1 News – Dermatologist Dr. Ellen Turner on CEO Money

In this week’s CEO Money segment Michael Yorba sits down with Dallas dermatologist, Dr. Ellen Turner to learn about skin cancer, and why her practice is using Superficial Radiation Therapy (SRT) — a new, non-surgical skin cancer treatment option that has a remarkable cure rate. Read the full article and listen to the interview here.

Read More

2018 Practical Symposium

Join Sensus Healthcare at the 2018 Practical Symposium in Beaver Creek, CO August 9th – 12th, 2018. For tickets and more information click here.

Read More

Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit

BOCA RATON, Fla., June 12, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS),a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will participate in a panel discussion, titled “New Treatments for Rare/Orphan Diseases and Oncologic Conditions,” at […]

Read More

City & Shore – Alternative Treatment to Skin Cancer Surgery

City & Shore Magazine recently wrote an article regarding the alternative treatment options to skin cancer surgery. Dr. Jason Green, DO and SRT was featured in the article. Check out the full article here.

Read More

Practical Dermatology – Solving the Keloid Conundrum

Achieving complete keloid scar removal is extremely difficult. The SRT-100 is the only FDA approved removal option on the market. Recently the machine was featured in an article on Practical Dermatology’s website. Read the full article here.

Read More

The Aesthetic Show

Join Sensus Healthcare at The Aesthetic Show in Las Vegas, NV July 5th – 8th, 2018. For tickets and more information click here.

Read More

Fox News – The Best Sunscreens, According to a Top Dermatologist

Sunscreen is meant for the purpose of protecting your skin from the harmful UV rays that cause can sunburn and skin cancer. What you may not realize is that no two sunscreens are entirely alike. Lindsey Carlton from Fox News and dermatologist Dr. Whitney Bowe break down the best  sunscreens currently on the market and how […]

Read More

Sensus Healthcare to Present at the 8th Annual LD Micro Invitational

LOS ANGELES, CA / ACCESSWIRE / May 29, 2018 / Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that it will be presenting at the 8th Annual LD Micro Invitational on Tuesday, June 5 at 2:30pm PST/5:30pm […]

Read More

AuntMinnie.com – Sensus Names New VP of Clinical Development

May 21, 2018 — Superficial radiation therapy provider Sensus Healthcare has appointed Isabelle Raymond, PhD, as vice president (VP) of clinical development. Read the full article here.

Read More

Dr. Schewe Discusses the SRT-100 and Skin Cancer on Colorado News 9

Dr. Schewe from Alliance Cancer Care Colorado at Red Rocks discusses the revolutionary ways the SRT-100 treats skin cancer. Click the link or watch the video below to learn more.

Read More

Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development

BOCA RATON, Fla. (May 8, 2018) – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced the appointment of Dr. Isabelle Raymond, PhD, as Vice President, Clinical Development. Dr. Raymond, who will report to Joe Sardano, Sensus CEO, […]

Read More

ASMS – American Society for Mohs Surgery Annual Meeting: Focus on Skin Cancer

Join Sensus Healthcare at the 2018 ASMS – American Society for Mohs Surgery Annual Meeting: Focus on Skin Cancer in Orlando, FL May 24th-27th, 2018. For tickets and more information click here.

Read More

Medical Device News Magazine – Dr. Isabelle Raymond Appointed Vice President of Clinical Development of Sensus Healthcare

May 8, 2018 -Dr. Isabelle Raymond Appointed Vice President of Clinical Development of Sensus Healthcare.  Dr. Raymond, who will report to Joe Sardano, Sensus CEO, brings 14 years of medical device and pharmaceutical industry experience to the Company. Read the full article here.

Read More

AuntMinnie.com – Sensus Appoints New Sales VP for Oncology

May 8, 2018 — Superficial radiation therapy provider Sensus Healthcare has appointed Rita Gable as its new vice president of sales for oncology, effective immediately. Read the full article here.

Read More

DermWire – Sensus Appoints Rita Gable as VP of Sales, Oncology

May 3, 2018 –Sensus Healthcare, Inc. has appointed Rita Gable as Vice President of Sales – Oncology. Ms. Gable, who will report to Joe Sardano, Sensus CEO, has 15 years of sales experience, specializing in the oncology market. Read the full article here.

Read More

Sensus Healthcare Appoints Rita Gable as Vice President of Sales – Oncology

BOCA RATON, Fla., May 1, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced this morning the appointment of Rita Gable as Vice President of Sales – Oncology, effective immediately. Ms. Gable has 15 years of sales experience, specializing in […]

Read More

Sensus at the 2018 SCALE Meeting

Join Sensus Healthcare at the 2018 SCALE Meeting in Nashville, TN May 10th-12th, 2018. For tickets and more information click here.

Read More

Sensus at the 2018 ACMS Annual Meeting

Join Sensus Healthcare at the 2018 ACMS Annual Meeting in Chicago, IL May 3rd-6th, 2018. For tickets and more information click here.

Read More

Sensus Healthcare to Host First Quarter 2018 Financial Results and Business Update Conference Call on May 3, 2018

BOCA RATON, Fla., April 26, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, May 3, 2018 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2018. […]

Read More

Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments

BOCA RATON, Fla., April 19, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that the Company is expanding its global business with SRT to meet growing demand for non-invasive, highly effective skin cancer and keloid treatments. Rick […]

Read More

Sensus at the 2018 Texas Dermatological Society Users Meeting

Join Sensus Healthcare at the 2018 Texas Dermatological Society Users Meeting in Austin, TX April 27-28, 2018. For tickets and more information click here.

Read More

Sensus Healthcare at ASLMS 2018

Join Sensus Healthcare at the 2018 ASLMS conference in Dallas, TX April 11-15, 2018. Come and meet the new Sensus Laser Systems. Click here to register today!

Read More

Tony Perkins: A Keloid Removal Success Story in the Making

Tony Perkins is a public school teacher in St. Louis. Mr. Perkins has suffered with keloids on his neck and torso for 15 years. Although keloids are benign growths, the weight of them has caused neck pain for Tony. He had undergone several surgeries previously and noticed that the keloids would return within a few […]

Read More

Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

BOCA RATON, Fla. (March 8, 2018) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and multi-platform state of the art aesthetic lasers, today announced the Company will present at the B. Riley FBR Inaugural China Healthcare Investing […]

Read More

Sensus Healthcare Launches New Line of Laser Systems to Provide Patients with Full Spectrum of Clinical and Aesthetic Dermatological Solutions

BOCA RATON, Fla., March 5, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), announced today that the Company has launched Sensus Laser Systems, a unique multi-platform line of high-quality, cost-effective dermatological lasers to compliment Sensus’ existing SRT system. Sensus Laser Systems includes capabilities for hair and tattoo removal, acne lesion correction, skin rejuvenation and pigmentation/large pore treatment. Read […]

Read More

Skin Cancer, Take a Hike! – Following the Journey of Dr. Dan Siegel

It is estimated that someone dies from melanoma ever hour, and one in five Americans will be diagnosed with skin cancer. However, when skin cancer is detected early, it has a 98% cure rate. Dr. Dan Siegel is embarking on a journey through the Alaskan wilderness to spread awareness, detection and prevention of skin cancer […]

Read More

Dr. Kevin Schewe, M.D. Discusses SRT

Dr. Kevin Schewe, M.D. discusses the early signs and symptoms of skin cancer plus the revolutionary treatment of SRT. View the full interview with 9News.com here.

Read More

Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe

BOCA RATON, Fla., Feb. 7, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), announced today that the Company is opening a new office in Tel Aviv to deepen its presence in Israel, the Middle East and Europe—while continuing to bring Sensus’ innovative SRT treatment to patients all over the world who are afflicted with both non-melanoma skin cancers and keloids. Read the […]

Read More

NBNA – SRT-100, Game Changer for Keloid Treatment

Dr. Michael H. Gold, a previously featured physician in our Physician Spotlight, has been featured in the Fall 2017 issue of National Black Nurses Association News.  Read the article here. SRT-100, Game Changer for Keloid Treatment Treating keloids is very frustrating, not only for the patient suffering from them, but also for the health care […]

Read More

Sensus Healthcare Launches Collaboration with BirchBioMed

Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World On February 5th, 2018, Sensus Healthcare announced their collaboration with BirchBioMed, Inc. BirchBioMed, Inc., is a biomedical company focused on anti-scarring medications, to treat and prevent scarring more effectively for patients with keloids. Read the full press release […]

Read More

The Surgeon General’s Call to Action to Prevent Skin Cancer

The Surgeon General has released a Call to Action to address Skin Cancer as a major public health problem. The executive summary includes strategies for prevention with clear and concisely outlined goals. Click the link below to read the full article. The Surgeon General’s Call to Action to Prevent Skin Cancer

Read More

Global Keloid Treatment Market to Reach US $4.4 Billion by 2027

The expected increase of keloid scar occurrences, the shift from Mohs surgery as well as developments in advanced cryosurgery and radiation therapy devices will bring about an increase in the demand for keloid treatment. Read more: Global Keloid Treatment Market to Reach US $4.4 Billion by 2027

Read More

Sensus Healthcare at the 2018 South Beach Symposium

Sensus Healthcare will be at the 2018 South Beach Symposium. The event takes place in Miami Beach, FL March 1-4, 2018. Contact us today to schedule your demo at (561) 922-5808 x114. We look forward to seeing you there.

Read More

Sensus Healthcare at the 2018 AAD Annual Meeting

Sensus Healthcare will be at the 2018 AAD Annual Meeting. The event takes place in San Diego, CA February 16 – 20, 2018. Come by and visit is at booth #4407. Contact us today to schedule your demo at (561) 922-5808 x114. We look forward to seeing you there.

Read More

Medgadget Interview With CEO Joe Sardano

Sensus Healthcare’s FDA cleared low energy x-ray technology was the highlight of the discussion when Sensus Healthcare CEO, Joe Sardano, sat down with Medgadget’s Alice Ferng to discuss the benefits of using the SRT-100 and SRT-100 Vision. Click here to view the article.

Read More

Simple Daily Habits for Success – Inc.com

Looking to set yourself apart from the crowd in business or in life? Find out what Sensus Healthcare Co-Founder, Chairman and CEO, Joseph Sardano, has to say about it in Christina DesMarais’s article 24 Simple Daily Habits These High Achievers Swear by for Their Success on Inc.com. It’s that simple! “When you manage a results oriented […]

Read More

Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico

BOCA RATON, Fla. (October 31, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ is now cleared for sale in Mexico. The system is approved for the treatment of non-melanoma skin cancer and […]

Read More

Non-Melanoma Skin Cancer Treatment Market | Analysis and Key Trends 2025

24 OCTOBER 2017 BY MACIEJ HEYMAN Government initiatives to raise awareness of non-melanoma skin cancer Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Government authorities and regulatory bodies are working overtime to educate people about non-melanoma […]

Read More

Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment Care

Collaboration Brings Sensus Healthcare’s SRT Technology and Stratpharma’s Wound Care Medical Devices Together to Advance Radiation Patient Outcomes San Diego, Calif. (October 23, 2017) – Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss company that specializes in innovative film-forming full-contact topical medical products to improve medical and aesthetic outcomes in post-procedure care […]

Read More

John Berry & Friends All Come Together for Hurricane Relief

John Berry & Friends All Come Together for Hurricane Relief!

Read More

Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting

BOCA RATON, Fla. (October 9, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), announced today that an abstract was presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place on Oct. 5-8 in […]

Read More

American Society for Dermatologic Surgery Annual Meeting to Include Presentation on the Effectiveness of SRT

BOCA RATON, Fla., October 2, 2017 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiation Therapy (SRT), announced today that the 2017 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago will include a […]

Read More

Sensus Healthcare Installs Second Next-Generation SRT-100 Vision System in Israel to Treat Skin Cancer and Keloids

New SRT-100 Vision Now at Beilinson Hospital / Rabin Media Center in Petah Tikva BOCA RATON, Fla. – September 20, 2017 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancer and other skin conditions, such as keloids, with superficial radiotherapy (SRT), today announced that the Company […]

Read More

Skin Cancer Treatment: No Cutting, No Scarring, No Long Recovery Times

If you are one of the 3.5 million Americans diagnosed with non-melanoma skin cancer, you have a choice. Skin cancer treatment does not have to be a nightmare. With the SRT-100, patients can choose no cutting, no stitching, no scarring and no long recovery times.  

Read More

SRT: Innovating a Proven Treatment for Skin Cancer Treatment

Innovating upon a tried-and-true technology, an updated device is available for dermatologists to use to fight skin cancer. By Jeffrey Fromowitz, MD, FAAD As a dermatologist in practice in Boca Raton, FL, I am at the front lines of the ever-growing skin cancer epidemic. As such, I am always searching for new tools that allow me […]

Read More

SRT: Innovating a New Treatment for Skin Cancer Treatment

Innovating upon a tried-and-true technology, an updated device is available for dermatologists to use to fight skin cancer. BY JEFFREY FROMOWITZ, MD As a dermatologist in practice in Boca Raton, FL, I am upon this tried-and-true technology, created an updated at the front lines of the ever-growing skin cancer epidemic. As such, I am always […]

Read More

Sensus Healthcare Offers Non-Surgical Option for Non-Melanoma Skin Cancer

CEO Joseph Sardano says skin cancer is often catching up with people earlier in life than it used to. Sensus Healthcare Inc. (SRTS) is marketing devices that offer some non-melanoma skin cancer (NMSC) patients an alternative to traditional Mohs surgery. Boca Raton, Fla.-based Sensus’ superficial radiation therapy (SRT) technology allows doctors to apply radiation skin-deep, […]

Read More

Non-invasive procedure treats local residents’ non-melanoma skin cancer

Local residents are opting out of surgery, and are instead undergoing a non-invasive procedure for treatment of non-melanoma skin cancers. The SRT-100, which met standards set by the U.S. Food and Drug Administration, is a tool that’s relatively new to the Rio Grande Valley. “It compares very favorably with any other modality, including mole surgery, […]

Read More

Medical device company taps into 1.4 billion-person market with deal in China

Boca Raton medical device maker Sensus Healthcare has been cleared to expand operations in China, bringing its skin-treatment technology to a country with more than 1.4 billion people. Sensus Healthcare (NASDAQ: SRTS) has made a name for itself in the medical community with the SRT-100, a device sold to dermatology practices which non-invasively treats skin conditions, including keloids, […]

Read More

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids

BOCA RATON, Fla. (July 26, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]

Read More

“I feel more alive:” FOX6 viewers’ generosity helps man get debilitating keloids removed after insurance denial

Treatment with Sensus Healthcare’s SRT-100™ following surgical removal of this man’s keloids reduced the chance of recurrence to just 4%. Click here to view the full article on FOX6NOW.com.  

Read More

Sensus Healthcare to Exhibit at the 2017 American Association of Physicists in Medicine Annual Meeting

BOCA RATON, Fla. – July 19, 2017 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiation Therapy (SRT), announced that the Company will be exhibiting at the 2017 American Association of Physicists in Medicine (AAPM) […]

Read More

Advancing Keloid Treatment: A Novel Multimodal Approach to Ear Keloids

Michael E. Jones, MD,* Jennifer McLane, FNP,* Rachael Adenegan, FNP-C,* JoAnne Lee, PA-BC,* and Christine A. Ganzer, PMHNP, PhD† BACKGROUND/OBJECTIVE Management of keloids of the pinna, in particular, those located in the helix and antihelix and lobule that occur as complications of ear piercing. MATERIALS AND METHODS Retrospective analysis of 49 patients treated with extralesional […]

Read More

Skin cancer treatment technology provides alternative to surgery for skin cancer patients

Skin cancer generally appears within the first two to three millimeters of the surface of the skin. “The traditional way to treat skin cancer is surgery,” said Dr. Jeffrey Brackeen, with the Skin Cancer Institute of Lubbock. The SRT-100, he said, provides a non-invasive treatment option for skin cancer patients. The tool is relatively new […]

Read More

Non-surgical local skin cancer treatment

The National Cancer Institute estimates 40-50% of Americans age 65 and over will have skin cancer at least once. Joe Sardano with Sensus Healthcare stopped by to tell us about its SRT technology the company says provides patients a safe, non-surgical, cosmetically superior alternative that is fast, painless and proven effective. Source: CBS12

Read More

My New Favorite Thing: SUPERFICIAL RADIATION THERAPY

With Sensus’ superficial radiation therapy (SRT), we may be entering uncharted waters where keloid recurrence after surgery and SRT leads to no, or a very low, incidence of keloid recurrence. With this, we will change the paradigm in the treatment of keloids. The Sensus SRT-100 is a superficial radiation device that has FDA clearance—the first […]

Read More

3rd Annual American Cutaneous Oncology Society: SRT Best Practices Conference 2017 Recap Video

Read More

This Boca Raton company was named South Florida’s most ‘disruptive’

The Greater Miami Chamber of Commerce has named medical device company Sensus Healthcare the most “disruptive” technology startup for 2017. Boca Raton-based Sensus Healthcare specializes in non-invasive tools aimed at treating skin conditions, such as non-melanoma skin cancers. Its best-known device is the SRT-100 Vision, a device sold to dermatologists nationwide. The Technology Leader of […]

Read More

Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce

BOCA RATON, Fla., May 24, 2017 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiotherapy (SRT), has been awarded the 2017 Technology Leader of the Year for the Disruptive Technology category by The Greater Miami […]

Read More

The Doctor’s Ultimate Wish List for Ending the Skin Cancer Epidemic

Despite tireless public awareness campaigns aimed at encouraging sun-safe behaviors and advances in skin cancer detection, the rates of this all-too-common, but highly preventable cancer continue to rise. Nearly 9,500 Americans are diagnosed with skin cancer each day, and fully one in five Americans will develop skin cancer in their lifetime, according to the American […]

Read More

Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017

BOCA RATON, Fla., April 27, 2017 /PRNewswire/ — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announced today that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, May 4, 2017 to discuss the […]

Read More

Resurgence of cutaneous radiation therapy for skin cancer: Healio Interview with Dr. Clay Cockerell

This video is part of Healio’s video perspective series from the 2017 AAD Annual Meeting conference and has been published with the headline, “Resurgence of cutaneous radiation therapy for skin cancer.” During the two-minute video, Dr. Cockerell discusses the resurgence of radiation therapy largely due to new technology developed by Sensus Healthcare which ultimately provides […]

Read More

SRT-100 Physician Dr. Jeremy Sunseri Flashes Back to Rodeo Days

Below is a photo of Sensus Healthcare customer Jeremy Sunseri, MD, FAAD, of Sun Dermatology in Panama City, FL during his rodeo days.

Read More

Sensus Healthcare Chief Financial Officer Arthur Levine Photographed with Basketball Icon and Hall of Famer, Bill Walton

Sensus Healthcare Chief Financial Officer Arthur Levine attended the ROTH Capital Conference at Dana Point, CA. and is seen below with Basketball Icon and Hall of Famer, Bill Walton.

Read More

Dr. David J Goldberg Presents at AAD 2017

Superficial radiation advances as option for NMSC treatment David J. Goldberg, MD, JD, examined the genesis of the evolution of superficial radiation therapy (SRT) during “New and Emerging Therapies for Non-Melanoma Skin Cancers,” part of “New Emerging Therapies” (S022). Dr. Goldberg is a dermatologic surgeon at Skin Laser and Surgery Specialists of New York/New Jersey. […]

Read More

SRT-100 Vision featured on San Antonio News

SRT-100 Vision a New Technology Revolutionizing Skin Cancer Treatment Skin cancer—it’s the most common cancer in the United States. An estimated one in five Americans will develop skin cancer in their lifetimes, but there’s a new technology that’s revolutionizing how patients are treated and it’s in the San Antonio area. “I’ve had skin cancers now […]

Read More

Superficial radiation therapy offers effective alternative to Mohs surgery

Dr. David Goldberg spoke at the 2017 South Beach Symposium conference on how SRT technology has rapidly advanced in the past 30 years and how SRT is an effective way to eradicate tumors while maintaining or improving patients’ quality of life. Below is an excerpt from the article by Healio.com covering this presentation: MIAMI — Superficial […]

Read More

Superficial radiation therapy provides safe, aesthetic results for non-melanoma skin cancer patients

MIAMI — At South Beach Symposium 2017, symposium chairman Mark S. Nestor, MD, PhD, discusses the efficacy and cosmetic benefits of superficial radiation therapy to treat both non-melanoma skin cancer and recurring keloid scars. Nestor presented at the symposium on innovative breakthroughs in superficial radiation therapy, including new technology from Sensus Healthcare. To watch the […]

Read More

Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 – 12 in Miami

Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, […]

Read More

Sensus Healthcare CEO Shares A Look Into Skin Cancer Treatment

Sensus Healthcare Inc (NASDAQ: SRTS) (NASDAQ: SRTSU) is micro-cap manufacturer of superficial radiation therapy (SRT) devices for the treatment of skin cancer and keloids, which went public on the Nasdaq exchange in June. Benzinga recently had the chance to chat with the company’s CEO Joseph C. Sardano, who shared some insight into the company and […]

Read More

New study highlights need for routine skin cancer screening for all transplant patients

Drexel University College of Medicine study suggests all organ transplant recipients should receive total-body screenings for skin cancer

Read More

Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award

September 7, 2016 Boca Raton, FL Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award – Sensus Credited with Advancing Superficial Radiation Therapy as Viable Treatment Option for NMSC – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers […]

Read More

Sensus Healthcare (SRTSU) To Sponsor First International Keloid Symposium On September 8 And 9 In New York

August 31, 2016 Boca Raton, FL Sensus Healthcare (SRTSU) To Sponsor First International Keloid Symposium On September 8 And 9 In New York Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today announced that […]

Read More

Hear What Patients and Physicians Have to Say About the SRT-100™ for Keloid Treatment

Patients and physicians both are talking about revolutionary keloid treatment offered by the SRT-100™. Hear what they have to say. :

Read More

Mike Masterson: Arkansas Approves Zapping Cancers

By Mike Masterson Posted: August 2, 2016 at 5:45 a.m. Editor’s note: The original version of the column was published March 9, 2014. There the thing still was, frowning from the mirror. That crusty red spot on the very tip of my nose wasn’t going away despite weeks of salves. It appeared to be steadily […]

Read More

New Procedure Spares Skin Cancer Patients From Surgery

Colorado’s Attorney General Cynthia Coffman became among the first in the state to undergo treatment with the SRT-100™. Doctor Kevin Schewe at Red Rocks Radiation Center, in partnership with Presbyterian/St. Luke’s Medical Center and Sarah Cannon Research Institute, is the only one in Colorado offering Superficial Radiation Therapy with the SRT-100™ for patients with non-melanoma […]

Read More

Keloid Management: A Retrospective Case Review on a New Approach Using Surgical Excision, Platelet-Rich Plasma, and In-office Superficial Photon X-ray Radiation Therapy

Michael E. Jones; Cherrell Hardy, BSN, RN; and Julie Ridgway, BSN, RN Jones Keloids Paper – July 2016 Advances in Skin & Wound Care

Read More

Sensus Healthcare, Inc. Appoints Dr. Darrell Rigel to its Board of Directors

June 13, 2016 Boca Raton, FL Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the appointment of Darrell S. Rigel, MD, MS, to its Board of Directors.  Dr. Rigel is a Clinical Professor […]

Read More

Sensus Healthcare Rings the Opening Bell at the Nasdaq MarketSite

Sensus Healthcare participated in an opening bell ringing ceremony at the Nasdaq MarketSite on Thursday, June 9, 2016. With important employees, partners and families on hand, Sensus Healthcare’s Chief Executive Officer, Joseph Sardano, officially opened the trading day on Nasdaq. This ceremony comes on the heels of the successful Initial Public Offering (IPO) of Sensus […]

Read More

KCSA Strategic Communications Advises Sensus Healthcare on Successful IPO: Rings the NASDAQ Bell Along Side Sensus Management

June 10, 2016 New York, NY KCSA Strategic Communications, a leading provider of integrated communications solutions announced its participation in the opening bell ringing ceremony at the Nasdaq MarketSite for its client, Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as […]

Read More

Sensus Healthcare, Inc. Prices Initial Public Offering

June 02, 2016 Boca Raton, FL Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the pricing of its initial public offering of 2,000,000 units at a public offering price of $5.50 per unit, […]

Read More

ASDS: Skin Cancer Treatments Among Most Frequently Performed Procedures in 2015

Dermatologic surgeons performed nearly 10 million medical and cosmetic procedures in 2015 – up five percent since 2014 and 27 percent since 2012, according to the 2015 American Society for Dermatologic Surgery (ASDS) Survey on Dermatologic Procedures. For the fourth year in a row, skin cancer treatments ranked as the most-performed procedure (3.17 million) by ASDS members. […]

Read More

2nd Annual American Cutaneous Oncology Society: SRT Best Practices Conference 2016 Recap Video

Read More

Dr. Todd Plott of Dermatology Alliance Offers the SRT-100™

Dr. Todd Plott of Dermatology Alliance offers the SRT-100™ to his patients at his offices in Coppell and Keller, Texas. Watch the video below to hear all the reasons why Dr. Plott is excited to be able to provide his patients with Superficial Radiotherapy using the SRT-100™.

Read More

Sensus Healthcare Receives FDA 510k Clearance for Next Generation Image Guided Superficial Radiotherapy SRT-100 Vision(TM)

October 19, 2015 San Antonio, TX (GLOBE NEWSWIRE) Sensus Healthcare, the market leader in superficial radiation therapy treatment of skin cancer and keloids, announces FDA clearance for the next generation SRT-100 Vision™ system at the American Society for Radiation Oncology (ASTRO) 2015 exhibition in San Antonio, TX. The next generation SRT-100 Vision™ features unique integration […]

Read More

Man with Large Keloid Scars on his Face Searches for Treatment featured on The Doctors TV

Keenan first developed a keloid scar after he had the chicken pox when he was 9 years old. He had the keloid removed, but months later, others formed. Keenan has had seven surgeries in the past 20 years to remove large keloid scars from his face.   http://www.thedoctorstv.com/videos/man-with-large-keloid-scars-on-his-face-searches-for-treatment

Read More

Single Fraction Radiotherapy For Small Superficial Carcinoma Of The Skin

Chan S, Dhadda AS, Swindell R. Single fraction radiotherapy for small superficial carcinoma of the skin.ClinOncol (R CollRadiol). 2007 May;19(4):256-9. Epub 2007 Mar 26. Department of Clinical Oncology, Nottingham University Hospital NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. steve.chan@nuh.nhs.uk AIMS: To define the optimal dose and maximum tumour size of basal and squamous cell carcinoma […]

Read More

Non-Surgical Treatments Of Primary, Non-Melanoma Eyelid Malignancies: A Review

Murchison AP, Walrath JD, Washington CV. Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review. Clin Experiment Ophthalmol. 2011 Jan;39(1):65-83; quiz 92-3. doi: 10.1111/j.1442-9071.2010.02422.x. Epub 2011 Jan 31. Oculoplastic and Orbital Surgery Service, Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA. amurchison@willseye.org The diagnosis and management of periocular cutaneous malignancies are essential components of an ophthalmologist’s […]

Read More

Palliative Radiotherapy For Non-Melanoma Skin Cancer

Barnes EA, Breen D, Culleton S, Zhang L, Kamra J, Tsao M, Balogh J. Palliative radiotherapy for non-melanoma skin cancer. ClinOncol (R CollRadiol). 2010 Dec;22(10):844-9. Epub 2010 Aug 15. Department of Radiation Oncology, Odette Cancer Centre, Toronto, Ontario, Canada. toni.barnes@sunnybrook.ca AIMS: The primary objective of this study was to assess the rate of tumor response to the […]

Read More

Radiation Therapy For Bowen’s Disease Of The Skin

Lauren A. Lukas VanderSpek M.D, Gregory R. Pond M.Sc., Woodrow Wells M.D., F.R.C.P.C. and Richard W. Tsang M.D., F.R.C.P.C Int J RadiatOncolBiol Phys. 2005 Oct 1;63(2):505-10. Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. lauren.vanderspek@lrcc.on.ca Presented in poster form at the Annual Meeting of the American Society […]

Read More

Squamous Cell Carcinoma (SCC) in Situ on the Lip

Dermatology Association of Tallahassee Armand B. Cognetta Jr., M.D. Earl Stoddard M.D. Molly Warthan M.D. Jerry Edwards REMT-P, HT (ASCP)cm CSN: DAT004 January 28, 2011 Situational Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from […]

Read More

Basal Cell Carcinoma (BCC) of the Nose in a 103 Year Old Female

Dermatology Association of Tallahassee CSN: DAT001 September 06, 2010 Situational Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from about a 100-mile radius by dermatologists in lower Alabama, South Georgia and the Panhandle, as well […]

Read More

Multiple Sites on the Nose Treated with Mohs and Superficial X-ray

Dermatology Association of Tallahassee Armand B. Cognetta Jr., M.D. Earl Stoddard M.D. Molly Warthan M.D. Jerry Edwards REMT-P, HT (ASCP)cm CSN: DAT006 January 28, 2011 Situational Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from […]

Read More

Superficial Radiation of Previously Irradiated Nose

Dermatology Association of Tallahassee Armand B. Cognetta Jr., M.D. Molly Warthan M.D. Jerry Edwards REMT-P, HT (ASCP)cm CSN: DAT009 May 11, 2011 Situational Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from about a 100-mile […]

Read More

12 Years Post-Op Basal Cell Carcinoma on Nose Tip Treated with SRT

Dermatology Association of Tallahassee Armand B. Cognetta Jr., M.D. Molly Warthan M.D. Jerry Edwards REMT-P, HT (ASCP)cm CSN: DAT008 May 11, 2011 Situational Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from about a 100-mile […]

Read More

Basal Cell Carcinoma on the Nose Treated with SRT

Dermatology Association of Tallahassee Armand B. Cognetta Jr., M.D. Molly Warthan M.D. Jerry Edwards REMT-P, HT (ASCP)cm CSN: DAT007 May 11, 2011 Situational Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from about a 100-mile […]

Read More

Large Squamous Cell Carcinoma (SCC) in Situ on the Face

Dermatology Association of Tallahassee Armand B. Cognetta Jr., M.D. Molly Warthan M.D. Jerry Edwards REMT-P, HT (ASCP)cm Lyndsey Schimmel M.A. CSN: DAT003 October 27, 2010 Situational Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from […]

Read More

Large Squamous Cell Carcinoma (SCC) in Situ of the Forehead

Dermatology Association of Tallahassee Armand B. Cognetta Jr., M.D. Molly Warthan M.D. Jerry Edwards REMT-P, HT (ASCP)cm Lyndsey Schimmel M.A. CSN: DAT002 October 27, 2010 Situational Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from […]

Read More

Basal Cell Carcinoma on the Forehead

Dermatology Association of Tallahassee Armand B. Cognetta Jr., M.D. Earl Stoddard M.D. Molly Warthan M.D. Jerry Edwards REMT-P, HT (ASCP)cm CSN: DAT005 January 28, 2011 Institutional Overview Dermatology Associates is a seven-person dermatology group with two Mohs surgeons, a fellow, an in-house plastic surgeon, and a dermatopathologist. We care for patients referred to us from […]

Read More

Advanced Dermatology and Cosmetic Surgery Partners with Sensus Healthcare

August 07, 2015 Boca Raton, FL Advanced Dermatology and Cosmetic Surgery, the nation’s largest dermatology practice, partners with medical device company to help treat non-melanoma skin cancers and keloids. ADCS Clinics (“ADCS”) announced it has partnered with Sensus Healthcare LLC (Boca Raton, FL) to treat patients with non-melanoma skin cancers and keloids in a non-invasive and […]

Read More

FDA-Approved SRT-100™ Revolutionizes Keloid Scar Removal

July 27, 2013 New York, NY The Food and Drug Administration (FDA) has recently gave Sensus Healthcare the clearance to use its revolutionary product, the SRT-100, the green signal to treat hypertrophic scars and keloid scars, or simply referred to as keloids. Sensus Healthcare claims that this technological advance in treating keloids will provide patients […]

Read More

Sensus Healthcare Introduces High-Frequency Ultrasound Image Guidance Technology to Its Superficial Radiotherapy Device

July 1, 2015 Boca Raton, Florida Sensus Healthcare, a manufacturer and marketer of medical devices that incorporate superficial radiation therapy (SRT) for noninvasive treatment of non-melanoma skin cancers and keloids, will debut its SRT-100 Vision System™ at the American Association of Physicists in Medicine (AAPM) exhibition in Anaheim, Calif. The upcoming meeting brings together leading […]

Read More

ACOS Holds First Meeting on Best Practices in Superficial Radiation Therapy for Non-Melanoma Skin Cancers

June 10, 2015 Boca Raton, FL Leading Dermatologist Dr. Clay J. Cockerell Hosts Educational Event Chaired by Dr. Mark Nestor, President of ACOS The American Cutaneous Oncology Society (ACOS) brought together nearly 100 dermatologists to share the science and best practices of providing Superficial Radiation Therapy (SRT) to patients with non-melanoma skin cancer (NMSC). The first annual physicians meeting, […]

Read More

Head and neck keloid management: A retrospective early review on a new approach using surgical excision, platelet rich plasma and in-office superficial photon X-ray radiation

Michael Eugene Jones, Cherrell Jackee Hardy, Julie Marie Ridgway Jones Keloids Paper – June 2015

Read More

Sensus Healthcare Receives FDA Clearance to Treat Keloids with the SRT-100™

May 24, 2013 Boca Raton, FL Sensus Healthcare is pleased to announce that it has received clearance from the U.S. Food and Drug Administration to treat Keloids with the SRT-100™. The SRT-100™ is the leading alternative to surgery in treating Non Melanoma Skin Cancer and now is approved to treat Keloids caused by surgery or […]

Read More

Sensus Healthcare Teams Up with Jeffrey Klein MD and Dermatology Associates of Orange County to Offer Non-Invasive Procedure for Non-Melanoma Skin Cancers

May 19, 2015 Boca Raton, FL Sensus Healthcare, a manufacturer and marketer of medical devices that incorporate superficial radiation therapy (SRT) for noninvasive treatment of non-melanoma skin cancers and keloids, proudly announces a new physician-user to its roster of leading Dermatologists and Radiation Oncologists. World- renowned expert in skin cancer, general and cosmetic dermatology, Jeffrey Klein, MD, […]

Read More

Dr. William I. Roth Presenting Three SRT Cases

Making a strong case for the remarkable efficacy, safety, and peerless outcomes for non-melanoma skin cancer patients, Dr. William Roth reviews the background and history of superficial radiotherapy and its important role in treating NMSC patients. Dr. Roth is presenting three very compelling BCC and SCC cases with his patients, who chose SRT to treat […]

Read More

Lexington Plastic Surgeons – Keloids

Combining surgery and the SRT-100 is the most effect and successful way to treat and rid your patients of keloids. Keloids don’t have to be a chronic disease anymore!

Read More

Sensus Healthcare Presented with Prestigious New Product Innovation Leadership Award for Non-Melanoma Skin Cancer Therapy

March 21, 2014 Boca Raton, Florida Frost & Sullivan has recognized Sensus Healthcare with the 2014 North American award for New Product Innovation Leadership. Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value added features/benefits […]

Read More

SRT-100™ is an Optimal Therapy Modality for Non-Melanoma Skin Cancers

Featuring our SharpBeam precision superficial radiotherapy, the SRT-100™ is an excellent treatment option for patients with non-Melanoma (NMSC) skin cancers, such as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Ask your doctor about SRT-100™ when you weigh your treatment options!

Read More

Sensus Healthcare Announces its Exhibitor Attendance at the 71st Annual American Academy of Dermatology Meeting

February 22, 2013 Boca Raton, FL Sensus Healthcare is proud to announce their exhibitor participation in the 71st Annual American Academy of Dermatology Meeting in Miami Beach, FL on March 1-5, 2013. Visit booth #2701to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™, it’s unique characteristics and advantages over other NMSC treatment […]

Read More

Sensus Healthcare Receives Medical Device License from Health Canada

November 15, 2012 Boca Raton, FL Sensus Healthcare is proud to announce that it has received a Medical Device License from Health Canada, permitting the company to commence selling its advanced SRT-100™ in Canada. The SRT-100™ is a state-of-the-art therapy device for Non-Melanoma Skin Cancer. The SRT-100™ provides patients with a virtually pain-free, non-invasive treatment option, while […]

Read More

Sensus Healthcare Announces its Exhibitor Attendance at the 54th Annual ASTRO Meeting

September 28, 2012 Boca Raton, FL Sensus Healthcare is pleased to announce its exhibitor participation in the 54th Annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston, MA on October 28 – 31, 2012. Visit Booth #9054 to learn more about the advanced SRT-100™ superficial radiotherapy platform, it’s unique characteristics […]

Read More

Sensus Healthcare Announces the Publication of a Comprehensive Study on Treating Non-Melanoma Skin Cancer in JAAD

September 28, 2012 Boca Raton, FL Sensus Healthcare is pleased to announce the acceptance and publication of the most comprehensive study to date on treating Non Melanoma Skin Cancer (NMSC) with superficial radiotherapy (SRT) in the Journal of the American Academy of Dermatology (JAAD). The comprehensive study, which examined 1,715 NMSC lesions in 1,149 patients, […]

Read More

Sensus Healthcare Announces Sale of 100th Skin Cancer Treatment Device

September 26, 2012 Boca Raton, FL Sensus Healthcare is proud to announce a major milestone in selling its 100th SRT-100™ advanced superficial radiotherapy (SRT) system. The SRT-100™ is a global success for treating Non Melanoma Skin Cancer on all major continents. The SRT-100™ provides patients with a virtually pain-free non-invasive treatment option, while achieving excellent […]

Read More

Sensus Healthcare Announces Attendance at the 2012 Fall Clinical Dermatology Conference

September 24, 2012 Boca Raton, FL Sensus Healthcare is pleased to announce its attendance at the 2012 Fall Clinical Dermatology Conference at The Encore Hotel, Las Vegas, NV on October 4 – 7, 2012. Sensus will be demonstrating its advanced superficial radiotherapy platform, the SRT-100™ for the non- invasive treatment of skin cancer. Sensus will […]

Read More

Sensus Healthcare Installs an SRT-100™ at Froedtert & The Medical College of Wisconsin Cancer Center and Commences Collaborative Research Relationship

September 24, 2012 Boca Raton, FL Sensus Healthcare is pleased to announce that Froedtert & The Medical College of Wisconsin Cancer Center has chosen the SRT-100™ advanced superficial radiotherapy platform (SRT) as the latest addition to its comprehensive radiotherapy solutions for cancer. Froedtert & The Medical College Cancer Center is the first cancer center in […]

Read More

Sensus Healthcare Receives SFDA Approval to Sell the SRT-100™ in China

September 19, 2012 Boca Raton, FL Sensus Healthcare and Megatop MTC are pleased to announce the SFDA approval of the SRT-100™ advanced superficial radiotherapy platform to be sold in China. This approval allows Megatop MTC to begin their sales and marketing initiatives in China immediately. Megatop has already ordered 9 systems to be delivered in […]

Read More

Sensus Healthcare Announces the Sale of its SRT-100™ Superficial Radiotherapy Unit to Hong Kong Sanatorium & Hospital in Hong Kong

August 6, 2012 Boca Raton, FL Sensus Healthcare, the global leader in superficial radiotherapy for non-melanoma skin cancers, announces the purchase of their SRT-100™ therapy system by Hong Kong Sanatorium & Hospital of Hong Kong through their Chinese distributor, Megatop Medical Technologies Co., Ltd. Hong Kong Sanatorium & Hospital is one of the most prestigious […]

Read More

Sensus Healthcare Announces an Alliance with Mission Search Corporation to provide Commissioning Services for the Sensus SRT-100™

July 30, 2012 Boca Raton, Florida Sensus Healthcare, a global leader in superficial radiotherapy for non-melanoma skin cancers, is joining forces with Mission Search Corporation, a Tampa, Florida based healthcare search and staffing organization to provide commissioning services to Sensus’ clientele. Sensus Healthcare is taking new aim at non-melanoma skin cancer by focusing on the […]

Read More

Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients

May 18, 2012 Boca Raton, FL and Texas Dermatology Associates at Baylor University Medical Center of Dallas, TX are proud to announce the establishment of the SRT University™ Comprehensive Education Series for practitioners, healthcare professionals, and patients. SRT University™ will offer multi-tiered education and training curriculums for the provider and patient populations, thus increasing the […]

Read More

Dermatology Associates of Knoxville SRT-100™ Commercial

Dermatology Associates of Knoxville’s SRT-100™ commercial clip for non-surgical NMSC skin cancer treatment with Dr. Miller.  

Read More

Sensus Healthcare and Megatop MTC announce their first sale of the SRT-100™ Superficial Radiation Therapy system to the Prince of Wales Hospital in Hong Kong

July 27, 2011 Boca Raton, FL Sensus Healthcare is pleased to announce that the Prince of Wales Hospital in Hong Kong has become the first healthcare facility in the country to purchase and deploy an SRT-100™ non-invasive skin cancer treatment system. The SRT-100™ will provide the local patient community with the most effective, non-surgical, and pain […]

Read More

Sensus Healthcare Announces Its Exhibitor Participation at the 86th National Congress of SIDeMaST in Verona, Italy

May 23, 2011 Boca Raton, FL Sensus Healthcare is pleased to have exhibited at the 86th National Congress of SIDeMaST (The Italian Society of Dermatology) in Verona, Italy, May 18th – May 21st. Sensus Healthcare featured its SRT-100™ non-surgical, superficial photon therapy system for non-melanoma skin cancers. This year’s event was considered an important national […]

Read More

Sensus Healthcare Has Obtained ISO 13485:2003 Certification & CE Mark

May 23, 2011 Boca Raton, FL Sensus Healthcare is pleased to have obtained ISO 13485:2003 certification and CE (Conformité Européenne, which is French for “European Conformity”) mark. As regulatory requirements, standards, and high customer expectations continue to set the bar for medical product manufacturers and their suppliers, Sensus takes pride in its compliance and continued […]

Read More

Sensus Healthcare Announces Medical Director and Medical Advisory Board

February 14, 2011 Boca Raton, FL Sensus Healthcare has announced Dr. Armand B. Cognetta as its Medical Director and Chair of the Medical Advisory Board. Dr. Cognetta will provide clinical guidance and patient advocacy in the ongoing development of the Company’s leading Superficial Radiotherapy product platform, the SRT-100™, and also lead the Company’s multi-disciplinary Medical […]

Read More

Sensus Healthcare Announces The Formation of a Medical Advisory Board

February 14, 2011 Boca Raton, FL Sensus Healthcare has announced the formation of a Medical Advisory Board (MAB). Accepting to Chair this Board as Medical Director is Dr. Armand B. Cognetta, distinguished Dermatologist and founder of Dermatology Associates of Tallahassee, Florida. Dr. Cognetta is recognized as a leader and innovator in his field. Dr. Cognetta […]

Read More

Sensus Healthcare Announces the World Premiere of its Electronic Healthcare Records (EHR) System – Astrum™ EHR

February 1, 2011 Boca Raton, FL Sensus Healthcare has announced its new all-inclusive Electronic Health Records (EHR) system – Astrum™ EHR. Astrum™ EHR is offering a total solution without compromises that includes EHR/EMR, Practice Management (PM), Patient Healthcare Records (PHR), e-Prescription, powerful merchant engines, MU/PQRI/HIPAA full compliance, and many other seamlessly-integrated features that provide unparalleled, […]

Read More

Superficial X-ray in the Treatment of Basal and Squamous Cell Carcinomas

Dermatology Association of Tallahassee Armand B. Cognetta, MD Brett M. Howard, BA Henry P. Heaton, BA Earl R. Stoddard, MD Hyokyoung Grace Hong, PhD W. Harris Green, MD Background: Effective nonsurgical modalities are limited in the treatment of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Objective: We sought to evaluate the efficacy and […]

Read More

Sensus Healthcare Announces its Exhibitor Attendance at the 69th Annual American Academy of Dermatology Meeting

January 24, 2011 Boca Raton, FL Sensus Healthcare is proud to announce their exhibitor participation in the 69th Annual American Academy of Dermatology Meeting in New Orleans, LA on February 4-8, 2011. Visit booth #3921 to learn about the SRT-100™ low-dose non-invasive superficial radiotherapy (SRT) non-melanoma skin cancer therapy product line, the Sensus Skin Solutions™ professional […]

Read More

Sensus Healthcare Announces Strategic Partnership with Flagship Solutions Group

January 7, 2011 Boca Raton, FL Sensus Healthcare has established a strategic partnership with Flagship Solutions Group in order to merge joint interests in medical and IT solutions. Sensus Healthcare is teaming with Flagship SG in order to provide world-class IBM products and services to its current and future served markets. Through this strategic partnership […]

Read More

Sensus Healthcare unveils streamlined design for signature skin cancer treatment system at world’s largest radiation oncology conference – ASTRO

November 2, 2010 San Diego, CA A new technology company committed to providing a viable treatment option for millions of skin cancer sufferers unveiled a re-design of its signature system this week at the American Society for Radiation Oncology (ASTRO) Annual Conference. ASTRO is the largest radiation oncology society in the world, with more than […]

Read More

Sensus Healthcare Sells First SRT-100™ in Thailand

October 7, 2010 Boca Raton, FL Asoke Skin Hospital of Bangkok has become the first healthcare facility in Thailand to successfully complete the installation and deployment of the SRT-100TM non-invasive skin cancer treatment system, officials with Sensus Healthcare announced today. Thailand’s first and only specialized dermatologic and plastic surgery facility, Asoke Skin Hospital is a […]

Read More

Basal Cell and Squamous Cell Carcinoma – Radiotherapeutic Approaches

Renato G. Panizzon Department of Dermatology, University Hospital – CHUV, Lausanne, Switzerland Radiotherapeutic Approaches to Basal Cell and Squamous Cell Carcinomas and Some Other Skin Tumors

Read More

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

  1. 95%+ cure rates that rival surgery
  2. No anesthesia, cutting, bleeding, stitching or pain
  3. No downtime or lifestyle restrictions
  4. Super cosmesis, no unsightly scarring
  5. No need for post-treatment reconstructive surgeries